Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
3 hedge funds and large institutions have $621K invested in Osiris Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 8 closing their positions.
73% less funds holding
Funds holding: 11 → 3 (-8)
91% less capital invested
Capital invested by funds: $6.74M → $621K (-$6.11M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$2.45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$5.47M |
| 2 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$489K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$134K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$78K |
| 5 |
FPF
FNY Partners Fund
New York
|
-$76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIM
1
Freedom Investment Management
Hartford,
Connecticut
| $541K | +$2.45K | +383 | +0.5% |
|
2
Public Employees Retirement Association of Colorado
Denver,
Colorado
| $77K | – | – | – |
|
|
MAM
3
Meeder Asset Management
Dublin,
Ohio
| $3K | – | – | – |
|
|
HP
4
HealthInvest Partners
Stockholm,
Sweden
| – | -$5.47M | -1,140,222 | Closed |
|
|
5
Tudor Investment Corp
Stamford,
Connecticut
| – | -$489K | -101,788 | Closed |
|
|
6
Simplex Trading
Chicago,
Illinois
| – | -$134K | -27,970 | Closed |
|
|
7
California Public Employees Retirement System
Sacramento,
California
| – | -$78K | -16,300 | Closed |
|
|
FPF
8
FNY Partners Fund
New York
| – | -$76K | -16,000 | Closed |
|
|
IA
9
IFP Advisors
Tampa,
Florida
| – | -$21K | -4,450 | Closed |
|
OSIR Hedge Fund Activity: Q2 2017 in Review
3 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q2 2017, worth a combined $621K — down 91% from $6.74M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of OSIR and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Freedom Investment Management, adding an estimated $2.45K. The largest seller was HealthInvest Partners, exiting entirely with an estimated $5.47M sold.
- 3 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q2 2017, down from 11 in Q1 2017.
- Funds reported $621K of Osiris Therapeutics, Inc. Common Stock stock for Q2 2017, down 91% quarter-over-quarter.
- 0 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q2 2017 and 8 closed out, a net change of -8 holders.
- The largest Osiris Therapeutics, Inc. Common Stock buyer in Q2 2017 was Freedom Investment Management, an estimated $2.45K added.
- The largest Osiris Therapeutics, Inc. Common Stock seller in Q2 2017 was HealthInvest Partners, an estimated $5.47M sold.
Based on aggregated 13F filings for Q2 2017.